Jennison Associates LLC Edwards Lifesciences Corp Transaction History

Jennison Associates LLC

$167 Billion
Q2 2025

A detailed history of Jennison Associates LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Jennison Associates LLC holds 11,670,991 shares of EW stock, worth $898 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares

11,670,991

Previous 10,086,033 15.71%

Holding current value

$898 Million

Previous $731 Million 24.86%

% of portfolio

0.55%

Previous 0.52%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 01, 2025	BUY	$67.07 - $78.22 $106 Million - $124 Million	1,584,958 Added 15.71%	11,670,991 $913 Million
Q1 2025 May 02, 2025	BUY	$67.95 - $76.19 $175 Million - $196 Million	2,576,383 Added 34.31%	10,086,033 $731 Million
Q4 2024 Jan 24, 2025	BUY	$64.54 - $75.92 $485 Million - $570 Million	7,509,650 New	7,509,650 $556 Million
Q2 2022 Aug 02, 2022	BUY	$86.5 - $128.27 $689,232 - $1.02 Million	7,968 New	7,968 $758,000
Q2 2021 Aug 12, 2021	SELL	$83.84 - $104.76 $44.4 Million - $55.5 Million	-530,008 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$78.68 - $90.67 $164 Million - $189 Million	-2,084,561 Reduced 79.73%	530,008 $44.3 Million
Q4 2020 Feb 05, 2021	SELL	$71.69 - $91.23 $58.7 Million - $74.8 Million	-819,389 Reduced 23.86%	2,614,569 $239 Million
Q3 2020 Nov 04, 2020	BUY	$67.19 - $87.44 $43.7 Million - $56.8 Million	649,689 Added 23.33%	3,433,958 $274 Million
Q2 2020 Aug 06, 2020	BUY	$57.54 - $76.95 $93 Million - $124 Million	1,616,012 Added 138.33%	2,784,269 $192 Million
Q1 2020 May 06, 2020	SELL	$52.41 - $81.0 $195 Million - $302 Million	-3,723,204 Reduced 76.12%	1,168,257 $220 Million
Q4 2019 Feb 07, 2020	SELL	$71.7 - $82.09 $87.5 Million - $100 Million	-1,220,793 Reduced 19.97%	4,891,461 $1.14 Billion
Q3 2019 Nov 08, 2019	BUY	$61.55 - $75.43 $4.51 Million - $5.53 Million	73,248 Added 1.21%	6,112,254 $448 Million
Q2 2019 Aug 06, 2019	BUY	$55.74 - $64.41 $15.3 Million - $17.7 Million	275,182 Added 4.77%	6,039,006 $0
Q1 2019 May 10, 2019	BUY	$47.89 - $64.05 $79.1 Million - $106 Million	1,651,691 Added 40.17%	5,763,824 $1.1 Billion
Q4 2018 Feb 06, 2019	BUY	$46.41 - $56.94 $124 Million - $152 Million	2,667,749 Added 184.7%	4,112,133 $630 Million
Q3 2018 Nov 08, 2018	BUY	$45.7 - $58.03 $27.4 Million - $34.7 Million	598,735 Added 70.8%	1,444,384 $251 Million
Q2 2018 Aug 02, 2018	BUY	$42.45 - $51.3 $11.5 Million - $13.9 Million	270,048 Added 46.92%	845,649 $123 Million
Q1 2018 Apr 20, 2018	BUY	$37.19 - $47.45 $3.39 Million - $4.32 Million	91,122 Added 18.81%	575,601 $80.3 Million
Q4 2017 Jan 25, 2018	SELL	$33.79 - $39.39 $18.5 Million - $21.6 Million	-548,897 Reduced 53.12%	484,479 $54.6 Million
Q3 2017 Nov 03, 2017	BUY	$36.29 - $38.83 $37.5 Million - $40.1 Million	1,033,376	1,033,376 $113 Million

Others Institutions Holding EW

# of Institutions

1,438

Shares Held

484M

Call Options Held

2.93M

Put Options Held

1.57M

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $47.6B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jennison Associates LLC with notifications on news.

Account

Jennison Associates LLC Edwards Lifesciences Corp Transaction History